By Crystal Phend, Senior Staff Writer, MedPage Today
Published: December 15, 2009

SAN ANTONIO — A novel form of trastuzumab (Herceptin) with a chemotherapy-like conjugate attached appears to substantially improve outcomes in heavily-pretreated metastatic breast cancer, researchers said.

This entry was posted on Monday, January 11th, 2010 at 4:03 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.